ÂÜÀòÂÒÂ×

Oliver Dolan MBA, CPA has over 18 years of experience in finance leadership roles across public and private companies in the life sciences, pharmaceutical, and technology sectors. Currently, Oliver serves as the Senior Vice President of Finance at Korro Bio, Inc. From December 2020 to December 2023, Oliver held the position of Vice President of Accounting, Tax & Treasury at UNITY Biotechnology. Prior roles include Head of Finance at Haven, where Oliver contributed to a joint venture focused on innovative healthcare solutions, and Vice President of Finance at Compass Therapeutics. Oliver also served as Managing Director at CFGI, leading the Biotech Consulting Practice in Boston, and held senior finance roles at Babco Europe Limited and SkillSoft. Oliver began a career in auditing as an Audit Senior Associate at Ernst & Young. Educational qualifications include an MBA from MIT Sloan School of Management, cross-registered MBA from Harvard Business School, and a BCom with a focus on Accounting and Marketing from University College Dublin.